Short-term complications of intravitreal injection of triamcinolone acetonide

Retina

Volumn 28, Issue 1, 2008, Pages 66-70

  Roth, Daniel B ^a   Realini, Tony ^b   Feuer, William J ^c   Radhakrishnan, Ravi ^a   Gloth, Jonathan ^a   Heimmel, Mark R ^a   Fechtner, Robert D ^d   Yarian, David L ^a   Green, Stuart N ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b West Virginia University Eye Institute   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Complications; Endophthalmitis; Injection; Intraocular pressure; Intravitreal triamcinolone acetonide

Indexed keywords

ANTIBIOTIC AGENT; POVIDONE IODINE; STEROID; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; CHILD; ENDOPHTHALMITIS; EYE DISEASE; GLAUCOMA; HUMAN; HYPOPYON; INFECTIOUS COMPLICATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; KERATOPATHY; MAJOR CLINICAL STUDY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; STEROID THERAPY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHOROID DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RETINAL DISEASES; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 38049141027     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181593e38     Document Type: Article

References (16)

1. Jonas JB, Martus P, Degenring RF, Kreissig I, Akkoyun I. Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol 2005;123:1338-1343.
2. Patelli F, Fasolino G, Radice P, et al. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment. Retina 2005;25:840-845.
3. Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004;138:158-160.
4. Scott IU, Ip MS. It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: the SCORE study. Arch Ophthalmol 2005;123:581-582.
5. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003;110:1517-1525.
6. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-304.
7. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004;138:740-743.
8. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-598.
9. Jonas JB, Degenring R, Vossmerbauemer U, Kamppeter B. Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide. Eur J Ophthalmol 2005;15:462-464.
10. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 1998;26:277-281.
11. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
12. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001;29:2-6.
13. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
14. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 1963;70:492-499.
15. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 1965;4:198-205.
16. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.